Showing 381-390 of 3011 results for "".
Gene Expression Profile Testing in the Management of Malignant Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/gene-expression-profile-testing-in-the-management-ofmalignant-melanoma/23030/A test analyzes 31 specific genes in excised tumors to predict risk for metastasis.Physician Spotlight: J. Matthew Knight, MD, FAAD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-j-matthew-knight-md-faad/20561/Dermatologists must act now to extinguish burnout or risk dire consequences.Wardrobe
Malfunctionhttps://practicaldermatology.com/topics/practice-management/wardrobe-malfunction/20913/Top dermatologists share tips on dressing for success.Improving Staff Retention Through Performance Management
https://practicaldermatology.com/topics/practice-management/improving-staff-retention-through-performance-management/23920/A thoughtful and structured review process opens the lines of communication.Market Your Dermatology Practice with Infographics
https://practicaldermatology.com/topics/practice-management/market-your-dermatology-practice-with-infographics/23075/Don’t just show or tell. Do both!An Updated, Holistic Approach to Managing Hyperpigmentation
https://practicaldermatology.com/topics/pigmentary-disorders/an-updated-holistic-approach-to-managing-hyperpigmentation/20102/As an early adopter of Cyspera, Suneel Chilukuri, MD has witnessed the evolution of the topical formulation. Cyspera Intensive System provides a three-step holistic approach to skincare that supports healthier, brighter skin within about four to six weeks.A Matter of Scales
https://practicaldermatology.com/series/diversity-and-equity-in-dermatology/a-matter-of-scales/19917/The "classic" descriptions of skin diseases and the scales used to assess disease severity often are based on white skin. But skin diseases can appear differently across skin types. The panelists discuss the need for updated tools, including the need to rethink skin type scales.Buyer Beware: CBD Products May Peddle False Hope Amid Corona Fears
https://practicaldermatology.com/series/dermatology-dispatches/buyer-beware-cbd-products-may-peddle-false-hope-amid-corona-fears/19775/Any claims that a medical cannabinoid-based product can kill COVID-19 are “absolutely unsubstantiated,” warns Adam Friedman, MD. There is no evidence that these products contain any antiviral properties, and patients should be advised against believing such claims.Case Report: Treatment of Refractory Pemphigus Foliaceus with Rituximab; Financial Matters; AAD; ASDS Resources
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-treatment-of-refractory-pemphigus-foliaceus-with-rituximab-financial-matters-aad-asds-resources/21033/Manage Patient Inquiries—The Path to Practice Growth
https://practicaldermatology.com/topics/practice-management/manage-patient-inquiriesthe-path-to-practice-growth/21650/Practice-owning physicians should invest time and resources to ensure that staff convert inquiries to appointments.